Fortress Biotech, Inc.
Price Action
Technical Summary
CONSOLIDATINGFortress Biotech, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 47), showing significant lag compared to the market leaders. Earnings growth of 7% provides fundamental context to the price action. Investors should exercise caution due to high volatility (79% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.86 | +2.98% | ABOVE |
| 50 SMA | $2.61 | +13.20% | ABOVE |
| 100 SMA | $2.83 | +4.09% | ABOVE |
| 150 SMA | $3.01 | -1.85% | BELOW |
| 200 SMA | $2.99 | -1.43% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is FBIO in an uptrend right now?
FBIO has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is FBIO overbought or oversold?
FBIO's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.
Is FBIO outperforming the market?
FBIO has a Relative Strength (RS) Rating of 47 out of 99. FBIO is currently lagging the broader market.
Where is FBIO in its 52-week range?
FBIO is trading at $2.95, which is 65% of its 52-week high ($4.53) and 43% above its 52-week low ($1.75).
How volatile is FBIO?
FBIO has a Beta of 0.98 and 52-week volatility of 79%. It's less volatile than the S&P 500 - generally more stable.